Dual binding of an antibody and a small molecule increases the stability of TERRA G-quadruplex. by Yangyuoru, Philip M et al.
RNA Structures
DOI: 10.1002/anie.201408113
Dual Binding of an Antibody and a Small Molecule Increases the
Stability of TERRAG-Quadruplex**
Philip M. Yangyuoru, Marco Di Antonio, Chiran Ghimire, Giulia Biffi,
Shankar Balasubramanian,* and Hanbin Mao*
Abstract: In investigating the binding interactions between the
human telomeric RNA (TERRA) G-quadruplex (GQ) and its
ligands, it was found that the small molecule carboxypyrido-
statin (cPDS) and the GQ-selective antibody BG4 simulta-
neously bind the TERRAGQ. We previously showed that the
overall binding affinity of BG4 for RNA GQs is not
significantly affected in the presence of cPDS. However,
single-molecule mechanical unfolding experiments revealed
a population (48%) with substantially increased mechanical
and thermodynamic stability. Force-jump kinetic investigations
suggested competitive binding of cPDS and BG4 to the
TERRA GQ. Following this, the two bound ligands slowly
rearrange, thereby leading to the minor population with
increased stability. Given the relevance of G-quadruplexes in
the regulation of biological processes, we anticipate that the
unprecedented conformational rearrangement observed in the
TERRA-GQ–ligand complex may inspire new strategies for
the selective stabilization of G-quadruplexes in cells.
Non-canonical nucleic acid structures such as G-quadru-
plexes have recently attracted significant attention for their
potential roles in the regulation of biological processes.[1] G-
quadruplexes are formed with a minimum of four guanine
(G)-rich repeats in DNA or RNA sequences.[2] They consist of
a stack of planar guanine tetramers called G-quartets that are
stabilized by Hoogsteen hydrogen bonds and monovalent
cation coordination.[3] G-quadruplex-forming sequences are
prevalent in the human genome[4–6] and are particularly
enriched at telomeres and in the promoter regions of
genes.[7,8] The formation of stable G-quadruplex structures
in the telomeric 3’ overhang has been shown to have an
inhibitory effect on telomerase, an enzyme up-regulated in
a majority of cancer cells.[9] Therefore, the design of small-
molecule ligands that can selectively bind and stabilize DNA
G-quadruplexes (GQs) in cells has been intensively inves-
tigated as a potential strategy for cancer therapy.[10] It has
been shown that mammalian telomeres can be transcribed
into telomeric repeat-containing RNA (TERRA),[11] which
can also form G-quadruplexes in vivo.[12] More generally,
RNAG-quadruplexes have been shown to regulate biological
processes such as translation.[13,14] This provides a new route
to control these biological processes by using molecules that
selectively bind to the RNAGQs. We recently demonstrated
that RNAG-quadruplexes can form in the cytoplasm of cells
and that they can be stabilized and visualized by the selective
RNA GQ ligand carboxypyridostatin (cPDS)[15] and the
antibody BG4.[16] These observations have led to the possi-
bility of a multifaceted regulatory approach, for example,
through antibody–drug conjugates (ADCs).[17] It is still
unclear whether BG4 and cPDS can cooperatively bind and
stabilize an RNA GQ structure in a cellular context. A
ternary complex in which an antibody and a small molecule
can cooperatively stabilize a GQ would offer a novel
approach to target and stabilize these structures and support
the observed increase in BG4 staining upon treatment with G-
quadruplex ligands. Furthermore, it would be of great
significance to see whether the conformational rearrange-
ment widely observed in proteins[18–20] and other nucleic acid
structures[21,22] are also observed upon binding of ligands to G-
quadruplexes.
In this report, we investigated the dual binding of cPDS
and the BG4 antibody to the TERRA G-quadruplex. Using
a mechanical unfolding approach with laser tweezers, we
found that a minor TERRAG-quadruplex population (48%)
has increased mechanical and thermodynamic stability when
bound to both ligands. With force-jump kinetic investigations,
we revealed that the two ligands compete for the binding
initially, followed by a slow rearrangement that leads to the
formation of the ternary complex. This behavior suggests
a conformational transition during binding, which leads to
increased stability of the bound TERRA GQ. We anticipate
that this new binding strategy may inspire the development of
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ligands with more effective binding to specific G-quadruplex
structures.
To carry out single-molecule mechanical unfolding experi-
ments, the GQ-forming sequence 5’-UUA(GGG UUA)4-3’
(TERRA-G4) was sandwiched between two double-stranded
DNA/RNA hybrid spacers, which were separately attached to
two optically trapped polystyrene beads in a laser tweezers
instrument. The entire nucleic acid construct was mechan-
ically stretched and relaxed (Figure 1A) in a 10 mm Tris
buffer (pH 7.4) that contains 100 mm KCl at 23 8C in a micro-
fluidic chamber. Unfolding events, indicated by a sudden
change in contour length (DL) during mechanical stretching,
were recorded in force–extension (F–X) curves (Figure 1B).
Using probability density distribution of DL and bootstrap
statistical analyses (PoDNano,[23] see the Supporting Infor-
mation), the DL histograms were deconvoluted into two
major populations with Gaussian centers at 9.4 0.2 and 5.7
0.3 nm (Figure 1B inset). Consistent with earlier reports,[24]
these DL populations represent a GQ structure (9.4 nm) and
partially folded species (5.7 nm). The latter may assume a G-
Triplex[25,26] conformation. Similar DL populations were
observed when the TERRA-G4 was incubated with the
small-molecule ligand cPDS or the antibody BG4 (Figure 2,
bottom panels), which implies that these binding partners do
not significantly disrupt the formation of GQ or the G-Triplex
intermediate. In fact, there is a slight increase in the partially
folded population for the antibody and cPDS mixture, thus
suggesting that various intermediates are present as a result of
multiple binding pathways.
Next, we investigated the mechanical stability of the
TERRAGQbound to the antibody or cPDS. Previous studies
have shown that DNA GQs bound to ligands have increased
mechanical stability compared to free GQs.[27] Depending on
the time of measurement or the concentration of the ligands,
however, the fraction of bound GQ varies. To ascertain the
mechanical stability of bound TERRA species more accu-
rately, we analyzed the rupture forces of folded structures
when different species reached equilibrium after approxi-
mately 45 seconds of refolding, which was carried out at 0 pN
after mechanical unfolding of the structures formed in the
TERRA-G4 fragment (Figure 3, see the Supporting Infor-
mation for experimental details).
After deconvoluting the GQ and the partially folded
species,[25] the mechanical stability of each species was
analyzed in separate rupture-force histograms (Figure 4 for
GQ and Figure S1 in the Supporting Information for partially
folded species). The rupture-force histogram for the TERRA
Figure 1. Single-molecule mechanical unfolding and refolding experi-
ments. A) Laser tweezers set-up, in which a single-stranded RNA
containing a TERRA-4G sequence is sandwiched by two DNA–RNA
hybrid handles attached to two optically trapped beads. Inset shows
the structure of carboxypyridostatin (cPDS). B) Typical F–X curves
show different rupture forces for the G-quadruplexes bound to the
small molecule cPDS, the antibody, or both. Inset shows a blown-up
region of the rupture event.
Figure 2. Changes in contour length (DL) of the structures in the
TERRA construct. Top panels: DL histogram, middle: Kernel density
distribution, bottom: PoDNano of the kernel density distribution.
TERRA without ligands (A) or with 5 mm cPDS (B), 50 nm BG4 (C), or
50 nm BG4+5 mm cPDS (D). Solid curves depict Gaussian fitting.
Figure 3. Probability of G-quadruplex (GQ) formation against incuba-
tion time for TERRA without ligand (black), with cPDS (dark gray), or
with BG4 (light gray). The highlighted plateau indicates the equili-
brated folding state. Solid curves represent fitting from a two-state
model (see the Supporting Information).
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GQ without ligands shows more than one population (Fig-
ure 4A), representing multiple conformations in the same
TERRA sequence as reported previously.[24,28] When the
TERRA construct was incubated with 5 mm cPDS, we
observed an increase in the rupture forces (from 23/36 pN
to 25/40 pN), thus suggesting that the binding of cPDS
increases the mechanical stability of the TERRA GQ (Fig-
ure 4B). A similar increment in mechanical stability was
observed for TERRA-G4 with 50 nm BG4 (Figure 4C).
Interestingly, with a mixture of 5 mm cPDS and 50 nm BG4,
we observed two populations with rupture forces centered at
30 and 50 pN (Figure 4D), respectively. Compared to the
populations in the presence of either cPDS or BG4, these two
populations showed increased rupture forces. Whereas the
30 pN species can be contributed from the higher force
population in either cPDS or BG4 solutions, the 50 pN
population (48%) clearly suggests that the TERRA GQ has
two separate binding sites to simultaneously accommodate
BG4 and cPDS. Analyses of the change in the free energy of
unfolding (DGunfold) confirmed that this species is thermody-
namically more stable (17, 17, and 25 kcalmol1 for cPDS,
BG4, and cPDS+BG4 bound to TERRAGQs, respectively,
see Table S1 and Figure S2 in in the Supporting Information).
In fact, the extra DGunfold gained from the simultaneous
binding of the two ligands (DDGunfold= 9.1 kcalmol
1) is more
than the sum of those from the binding of cPDS or BG4 alone
(1.3+ 1.4= 2.7 kcalmol1). This fact indicates the presence of
additional interactions between the two binding sites, prob-
ably as a result of conformational rearrangement during
binding of the ligands, a characteristic of allosteric effects. It is
noteworthy that the rupture-force histograms of the partially
folded species remained unaffected after incubation with
cPDS, BG4, or both (Figure S1), thus suggesting that the
ligand or antibody binds to the TERRA GQ rather than
a partially folded TERRA species such as a G-Triplex.
Consistent with what was observed in the DL populations
(Figure 2D), a slight increase in the low-rupture-force
population was observed in the presence of both cPDS and
BG4 ligands, which again suggests the presence of multiple
intermediates as pathways to ligand binding become more
complex (Figure 4).
To follow individual species with a better temporal
resolution, we performed single-molecule kinetic experi-
ments using the force-pumping and force-probing
approach.[27,29] As soon as we mechanically unfolded
TERRA GQs, we relaxed the force to 0 pN within 10 ms to
allow the GQs to refold (force-pumping). The folding of the
structure during incubation is probed by the next round of the
force-ramping procedure (force-probing). As shown in Fig-
ures 3 and 5, while cPDS provides the biggest increase in
folding rate for the TERRA GQ, the antibody BG4 has the
Figure 4. Rupture-force histograms for TERRA G-quadruplexes without
ligands (A), with 5 mm cPDS (B), with 50 nm BG4 (C), or with 5 mm
cPDS+50 nm BG4 (D). Gaussian fitting (dotted curves) reveal two
major populations. The higher force populations are indicated by
dotted arrows.
Figure 5. Two-stage binding of cPDS (5 mm) and BG4 (50 nm) to the
TERRA G-quadruplex. A) Folding kinetics of the TERRA G-quadruplex
in solutions without ligands (black) or with cPDS+BG4 (red). The
purple data points depict the folding kinetics of the species with
rupture force>43 pN in the presence of both BG4 and cPDS. B) Fold-
ing rate constants (kfold) of TERRA G-quadruplexes under different
conditions. C) Schematic of the proposed two-stage binding. The
formation rate constant for G-quadruplex is indicated by the thickness
of each arrow.
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least effect. When both cPDS and BG4 are present, an
intermediate increase in the folding rate was observed. If the
binding of cPDS and BG4 were not competitive, the
formation of the GQ would follow the fastest binding kinetics
determined by cPDS alone. Therefore, our results indicate
that BG4 competes with cPDS for initial binding.
Since the GQ bound to both cPDS and BG4 (rupture
force> 43 pN) can be clearly differentiated from the singly
bound species or free quadruplexes, we deconvoluted this
species (rupture force> 43 pN) and followed its folding
kinetics. As shown in Figure 5A,B, the folding kinetics of
this species is slowest even compared to that of free TERRA
GQ. Based on the kinetics observed in the presence of
different ligands, we reconstructed the folding pathways of
TERRA GQ in a two-stage process in the cPDS and BG4
mixture (Figure 5C). In the first stage, formation of the GQ is
mediated by competitive binding of cPDS and BG4. Since
folding of the GQ is fastest in the presence of cPDS, the
cPDS-bound GQ (process I in Figure 5C) represents the
predominant species at the end of this stage. In the second
stage, the cPDS-bound species started to accept BG4 and
slowly rearranged to finalize the binding complex for both
cPDS and BG4 (process V in Figure 5C). As a result, the
ternary complex becomes more stable both mechanically and
thermodynamically, the latter of which was suggested pre-
viously by immunofluorescence[16] and demonstrated in this
work by means of the optical tweezers measurements
(Table S1) and FRET-melting experiments (Figure S3). Sim-
ilar synergistic effects from different ligands have been
observed in both ensemble[30] and single-molecule experi-
ments.[31]
In summary, we have observed conformational rearrange-
ment during the simultaneous binding of the GQ-selective
BG4 antibody and the small molecule cPDS to the TERRA
GQ. We anticipate that the increased mechanical and
thermodynamic stability resulting from the conformational
rearrangement could provide new leads for the design of
more effective GQ-binding ligands.
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